Attention Bias Study for Infants of Mothers with Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to study how infants of mothers with postpartum depression react to emotional facial expressions and how their level of arousal (alertness or excitement) might influence this response. Researchers will engage infants in simple tasks, such as looking at different faces (Interaction Task and Passive Viewing Task), to determine if a link exists between their responses and their mothers' mental health. Mothers who have experienced major depression since their baby's birth or have no history of depression can participate, and their full-term, healthy infants are eligible. As an unphased trial, this study offers a unique opportunity to contribute to understanding the early emotional development of infants.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe for infants?
Research has shown that both the Interaction Task and the Passive Viewing Task are safe for infants. These tasks are non-invasive, meaning they do not physically enter the body or cause harm.
The Interaction Task examines how mothers and babies interact, particularly when the mother has postpartum depression. Although depression can affect these interactions, the task itself is harmless. It simply observes how infants respond to their mothers and surroundings.
In the Passive Viewing Task, infants view different facial expressions, such as happy or neutral faces. This task uses eye tracking, a safe method that monitors where and how infants look at things. Similar tasks have been safely used in other studies with children and infants sitting on their mothers' laps.
Overall, both tasks are well-tolerated by infants, with no reports of negative effects from similar studies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to understand and potentially help infants of mothers with depression. Unlike traditional treatment methods that focus on medication or adult therapy, this trial uses unique interaction and passive viewing tasks to observe how these infants process attention. This could reveal important insights about early development in a high-risk group, potentially leading to innovative, non-invasive interventions that support healthier emotional development from an early age.
What evidence suggests that this trial's treatments could be effective for infants of mothers with depression?
Research shows that babies of mothers with postpartum depression often react differently to emotional faces. One study found that a mother's depression can affect her baby's learning and social growth. Another study observed that babies with depressed mothers had different brain reactions when looking at their mother's face compared to other faces. These differences might arise because the mother's depression affects how she responds to and interacts with her baby. In this trial, all infants will participate in both the Interaction Task and Passive Viewing Task. These tasks could help researchers understand and address these attention differences in babies.36789
Are You a Good Fit for This Trial?
This study is for infants born full-term and normal weight, without health problems. Their mothers are divided into two groups: one with no history of depression (low-risk group) and another who had major depressive disorder (MDD) after giving birth (high-risk group). Mothers must not have substance use disorders or a history of bipolar/psychotic disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Infants complete a computer-based task viewing facial displays of emotion while an eye tracker records their gaze. Mother and infants complete a standardized interaction task assessing infant gaze and psychophysiology.
Follow-up
Participants are monitored for changes in eye gaze, heart rate, and respiratory sinus arrhythmia at 3-, 6-, 9-, and 12-month intervals.
What Are the Treatments Tested in This Trial?
Interventions
- Interaction Task
- Passive Viewing Task
Find a Clinic Near You
Who Is Running the Clinical Trial?
Binghamton University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator